Anergy is a term in immunobiology that describes a lack of reaction by the body's defense mechanisms to foreign substances, and consists of a direct induction of peripheral lymphocyte tolerance. An individual in a state of anergy often indicates that the immune system is unable to mount a normal immune response against a specific antigen , usually a self-antigen. Lymphocytes are said to be anergic when they fail to respond to their specific antigen. Anergy is one of three processes that induce tolerance, modifying the immune system to prevent self-destruction the others being clonal deletion and immunoregulation. This phenomenon was first described in B lymphocytes by Gustav Nossal and termed "clonal anergy.
|Published (Last):||24 April 2019|
|PDF File Size:||16.41 Mb|
|ePub File Size:||19.2 Mb|
|Price:||Free* [*Free Regsitration Required]|
Language: English French. Possible models to test this hypothesis are discussed. National Center for Biotechnology Information , U. Res Immunol. Published online Dec 9. Author information Copyright and License information Disclaimer. Elsevier hereby grants permission to make all its COVIDrelated research that is available on the COVID resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source.
This article has been cited by other articles in PMC. References Anderson R. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease.
Is immune oversuppression the direct cause of AIDS? Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature Lond. HIV revealed. New Engl. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. Plasma viremia in human immunodeficiency virus infection.
Characterization of T-lymphocyte responses during primary HIV infection. Microbiology 3d ed. J Acq. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Potential mechanisms for the cytopathic properties if HIV. Quantitation of human immuno-deficiency virus type 1 in the blood of infected persons. Immunological studies in the acquired immunodeficiency syndrome-II.
Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. Spontaneous suppressor cell activity in patients with AIDS and associated conditions.
Allergy clin. Soluble suppressor factors in patient with acquired immunodeficiency syndrome and its prodrome: elaboration in vitro by T-lymphocyte-adherent cell interactions.
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Mysteries of HIV: challenges for therapy and prevention. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. Cells involved in the immune response. In: Roitt I. Churchill Livingstone; Edinburgh: In vitro cellular tropism of human B-lymphotropic virus human herpesvirus-6 J. Evidence for an abnormality affecting individual helper and suppressor T cells.
Evidence that prior immune dysfunction predisposes to HIV infection in homosexual men. Immune Def. Fast-acting slow viruses. Immunological abnormalities in human immunodeficiency virus HIV infected asymptomatic homosexual men. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.
Do tolerant T cells exist? Correlation of spontaneous suppressor cell activity with progression of human immunodeficiency virus infection. AIDS Res. Hum Retro. Immunologic tolerance: collaboration between antigen and lymphokines.
Extensive variation of human immunodeficiency virus type-1 in vivo. The immunopharmacology of cyclophosphamide. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of AIDS. Early T-helper cell defects in HIV infection. Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using PCR. The effect of antineoplastic drugs on murine acquired immunodeficiency syndrome.
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. Heterophil-negative mononucleosis-like illness with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus. Cytotoxic effector cells specific for B-cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis; pp.
Primary HIV infection: host responses and intervention strategies. RNA tumor viruses. Defective viruses to blame? Human immunodeficiency virus type 1 HIV-1 infection a median of 18 months before a diagnostic Western blot. Evidence from a cohort of homosexual men.